Learn More
We report a genome-wide association study (GWAS) of major depressive disorder (MDD) in 1221 cases from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study and 1636 screened controls. No genome-wide evidence for association was detected. We also carried out a meta-analysis of three European-ancestry MDD GWAS data sets: STAR*D, Genetics(More)
SUPPLEMENTARY METHODS AND RESULTS This document contains supplementary material for: Shi et al. Genomewide association study of recurrent early‐onset major depressive disorder (GenRED GWAS); and Shyn et al: Novel loci for major depression identified by genome‐wide association study of STAR*D and meta‐analysis of three studies. Table of
  • 1